BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29567775)

  • 21. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
    N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
    Karube K; Scarfò L; Campo E; Ghia P
    Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
    J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
    Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal B-cell lymphocytosis in individuals from sporadic (non-familial) chronic lymphocytic leukemia families persists over time, but does not progress to chronic B-cell lymphoproliferative diseases.
    Matos DM; Furtado FM; Falcão RP
    Rev Bras Hematol Hemoter; 2015; 37(5):292-5. PubMed ID: 26408361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous presentation of chronic lymphocytic leukemia as unique extramedullar involvement in a patient with normal peripheral blood lymphocyte count (monoclonal B-cell lymphocytosis).
    Tapia G; Mate JL; Fuente MJ; Navarro JT; Fernández-Figueras MT; Juncà J; Ferrándiz C; Ariza A
    J Cutan Pathol; 2013 Aug; 40(8):740-4. PubMed ID: 23639136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal B-cell lymphocytosis.
    Rawstron AC
    Hematology Am Soc Hematol Educ Program; 2009; ():430-9. PubMed ID: 20008229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
    Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada.
    Healey R; Patel JL; de Koning L; Naugler C
    Leuk Res; 2015 Apr; 39(4):429-34. PubMed ID: 25703352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia.
    Marti GE; Carter P; Abbasi F; Washington GC; Jain N; Zenger VE; Ishibe N; Goldin L; Fontaine L; Weissman N; Sgambati M; Fauget G; Bertin P; Vogt RF; Slade B; Noguchi PD; Stetler-Stevenson MA; Caporaso N
    Cytometry B Clin Cytom; 2003 Mar; 52(1):1-12. PubMed ID: 12599176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological and phenotypic features of chronic NK cell lymphocytosis identified among patients with asymptomatic lymphocytosis.
    Cao F; Zhao H; Li Y; Dai S; Wang C
    Int J Lab Hematol; 2015 Dec; 37(6):783-90. PubMed ID: 26234181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
    Slager SL; Lanasa MC; Marti GE; Achenbach SJ; Camp NJ; Abbasi F; Kay NE; Vachon CM; Cerhan JR; Johnston JB; Call TG; Rabe KG; Kleinstern G; Boddicker NJ; Norman AD; Parikh SA; Leis JF; Banerji V; Brander DM; Glenn M; Ferrajoli A; Curtin K; Braggio E; Shanafelt TD; McMaster ML; Weinberg JB; Hanson CA; Caporaso NE
    Blood; 2021 Apr; 137(15):2046-2056. PubMed ID: 33512457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).
    Rawstron AC; Shanafelt T; Lanasa MC; Landgren O; Hanson C; Orfao A; Hillmen P; Ghia P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S19-23. PubMed ID: 20839333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal B-cell lymphocytosis in the population of Slovenian region of Lower Carniola.
    Bajuk P; Furlan T; Černelč P; Čeh M; Podgornik H
    Int J Lab Hematol; 2016 Aug; 38(4):341-6. PubMed ID: 27061425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis.
    Kostopoulos IV; Paterakis G; Pavlidis D; Kastritis E; Terpos E; Tsitsilonis OE; Papadhimitriou SI
    Blood Cancer J; 2017 Aug; 7(8):e597. PubMed ID: 28841209
    [No Abstract]   [Full Text] [Related]  

  • 37. Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?
    Xochelli A; Kalpadakis C; Gardiner A; Baliakas P; Vassilakopoulos TP; Mould S; Davis Z; Stalika E; Kanellis G; Angelopoulou MK; McIver-Brown N; Ibbotson R; Sachanas S; Korkolopoulou P; Athanasiadou A; Anagnostopoulos A; Papadaki HA; Papadaki T; Stamatopoulos K; Pangalis GA; Oscier D
    Blood; 2014 Feb; 123(8):1199-206. PubMed ID: 24300853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
    Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
    Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
    Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
    Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
    Rollins-Raval MA; Fisher J; Craig FE
    Cytometry B Clin Cytom; 2013 May; 84(3):149-56. PubMed ID: 23475845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.